Genocea Biosciences (GNCA) Tops Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. ZETA
9. DAL
10. TMUS

Go back to Genocea Biosciences (GNCA) Tops Q4 EPS by 3c

Genocea Reports Fourth Quarter and Year-End 2015 Financial Results

February 11, 2016 7:30 AM EST

- Multiple 2016 clinical milestones for GEN-003 for genital herpes anticipated -- Cancer vaccine strategy targeting generation of first clinical candidate in 2017 -

CAMBRIDGE, Mass., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today reported corporate highlights and financial results for the fourth quarter and year ended December 31, 2015.

"2015 was another year of important progress for our lead product candidate, GEN-003 for genital herpes, and our ATLASTM T cell target... More